Edwards Lifesciences ROE 2006-2018 | EW

Current and historical return on equity (ROE) values for Edwards Lifesciences (EW) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Edwards Lifesciences ROE for the three months ending September 30, 2018 was 30.11%.
Edwards Lifesciences ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2018-09-30 $0.71B $3.36B 22.41%
2018-06-30 $0.66B $3.16B 20.98%
2018-03-31 $0.56B $3.25B 18.20%
2017-12-31 $0.58B $2.96B 19.76%
2017-09-30 $0.75B $3.16B 25.99%
2017-06-30 $0.72B $2.94B 26.05%
2017-03-31 $0.66B $2.74B 24.97%
2016-12-31 $0.57B $2.62B 22.62%
2016-09-30 $0.55B $2.69B 22.16%
2016-06-30 $0.53B $2.47B 21.83%
2016-03-31 $0.52B $2.30B 21.66%
2015-12-31 $0.50B $2.50B 21.00%
2015-09-30 $0.46B $2.42B 20.32%
2015-06-30 $0.44B $2.29B 20.14%
2015-03-31 $0.87B $2.21B 41.80%
2014-12-31 $0.81B $2.19B 43.31%
2014-09-30 $0.78B $2.04B 45.42%
2014-06-30 $0.76B $1.92B 48.68%
2014-03-31 $0.31B $1.34B 20.67%
2013-12-31 $0.39B $1.54B 25.29%
2013-09-30 $0.40B $1.44B 26.48%
2013-06-30 $0.40B $1.58B 25.54%
2013-03-31 $0.37B $1.59B 24.50%
2012-12-31 $0.29B $1.48B 19.93%
2012-09-30 $0.27B $1.54B 18.60%
2012-06-30 $0.25B $1.44B 17.98%
2012-03-31 $0.24B $1.39B 17.41%
2011-12-31 $0.24B $1.34B 17.44%
2011-09-30 $0.24B $1.36B 17.68%
2011-06-30 $0.24B $1.39B 17.79%
2011-03-31 $0.24B $1.36B 18.73%
2010-12-31 $0.22B $1.31B 18.20%
2010-09-30 $0.20B $1.23B 17.33%
2010-06-30 $0.23B $1.12B 20.19%
2010-03-31 $0.22B $1.15B 19.80%
2009-12-31 $0.23B $1.16B 22.03%
2009-09-30 $0.22B $1.09B 22.58%
2009-06-30 $0.18B $1.00B 19.46%
2009-03-31 $0.17B $0.94B 19.14%
2008-12-31 $0.13B $0.88B 15.05%
2008-09-30 $0.11B $0.88B 12.64%
2008-06-30 $0.10B $0.90B 12.36%
2008-03-31 $0.10B $0.78B 12.08%
2007-12-31 $0.11B $0.84B 13.90%
2007-09-30 $0.12B $0.82B 14.91%
2007-06-30 $0.12B $0.81B 15.24%
2007-03-31 $0.12B $0.79B 15.82%
2006-12-31 $0.13B $0.75B 17.93%
2006-09-30 $0.15B $0.73B 20.81%
2006-06-30 $0.12B $0.72B 16.74%
2006-03-31 $0.10B $0.72B 13.89%
2005-12-31 $0.08B $0.69B 12.03%
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $31.075B $3.435B
Edwards Lifesciences Corporation provides products and technologies to treat late-stage cardiovascular disease. The Company's products include tissue replacement heart valves, heart valve repair products, hemodynamic monitoring devices, angioscopy equipment, oxygenators, and pharmaceuticals. Edwards Lifesciences Corporation is headquartered in Irvine, California.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $94.638B 22.05
Intuitive Surgical (ISRG) United States $56.945B 56.03
Fresenius Medical Care AG KGaA (FMS) Germany $24.473B 16.57
IDEXX Laboratories (IDXX) United States $16.961B 48.45
ABIOMED (ABMD) United States $14.078B 101.15
DexCom (DXCM) United States $12.334B 0.00
Teleflex (TFX) United States $11.768B 26.71
Hologic (HOLX) United States $10.836B 17.78
Varian Medical Systems (VAR) United States $10.500B 26.01
STERIS (STE) United Kingdom $9.837B 26.10
Masimo (MASI) United States $5.746B 37.26
LivaNova (LIVN) United Kingdom $5.698B 36.58
Globus Medical (GMED) United States $4.956B 31.14
Penumbra (PEN) United States $4.483B 270.69
Integra LifeSciences Holdings (IART) United States $4.474B 21.79
Wright Medical Group (WMGI) Netherlands $3.542B 0.00
Cantel Medical (CMD) United States $3.428B 34.54
Inogen (INGN) United States $2.825B 60.97
Integer Holdings (ITGR) United States $2.671B 22.35
Halyard Health (AVNS) United States $2.230B 20.09
Glaukos (GKOS) United States $1.993B 0.00
OPKO Health (OPK) United States $1.808B 0.00
Tandem Diabetes Care (TNDM) United States $1.799B 0.00
Mazor Robotics (MZOR) Israel $1.532B 0.00
AxoGen (AXGN) United States $1.233B 0.00
Nevro (NVRO) United States $1.183B 0.00
Luminex (LMNX) United States $1.156B 41.84
Pacific Biosciences Of California (PACB) United States $1.135B 0.00
Orthofix (OFIX) United States $1.086B 31.37
Tactile Systems Technology (TCMD) United States $1.068B 169.97
CryoLife (CRY) United States $1.050B 92.07
Natus Medical (BABY) United States $1.021B 21.44
Intersect ENT (XENT) United States $0.939B 0.00
Accelerate Diagnostics (AXDX) United States $0.770B 0.00
AngioDynamics (ANGO) United States $0.765B 26.75
Mesa Laboratories (MLAB) United States $0.761B 45.02
TransEnterix (TRXC) United States $0.648B 0.00
Veracyte (VCYT) United States $0.540B 0.00
Sientra (SIEN) United States $0.530B 0.00
ViewRay (VRAY) United States $0.485B 0.00
SI-BONE INC (SIBN) United States $0.410B 0.00
Accuray (ARAY) United States $0.398B 0.00
Oxford Immunotec Global (OXFD) United Kingdom $0.394B 0.00
OrthoPediatrics (KIDS) United States $0.338B 0.00
Neuronetics (STIM) United States $0.327B 0.00
Quotient (QTNT) Switzerland $0.321B 0.00
Nuvectra (NVTR) United States $0.313B 0.00
Fluidigm (FLDM) United States $0.297B 0.00
SeaSpine Holdings (SPNE) United States $0.294B 0.00
IRadimed (IRMD) United States $0.282B 73.66
RTI Surgical (RTIX) United States $0.279B 44.00
GenMark Diagnostics (GNMK) United States $0.254B 0.00
CRH Medical (CRHM) Canada $0.238B 41.00
Corindus Vascular Robotics (CVRS) United States $0.226B 0.00
Helius Medical Technologies (HSDT) United States $0.216B 0.00
Pulse Biosciences (PLSE) United States $0.209B 0.00
T2 Biosystems (TTOO) United States $0.193B 0.00
Ekso Bionics Holdings (EKSO) United States $0.132B 0.00
Alphatec Holdings (ATEC) United States $0.127B 0.00
HTG Molecular Diagnostics (HTGM) United States $0.103B 0.00
Ra Medical Systems (RMED) United States $0.103B 0.00
Second Sight Medical Products (EYES) United States $0.100B 0.00
Sensus Healthcare (SRTS) United States $0.094B 0.00
Restoration Robotics (HAIR) United States $0.077B 0.00
Apollo Endosurgery (APEN) United States $0.071B 0.00
Biosig Technologies (BSGM) United States $0.071B 0.00
EDAP TMS (EDAP) France $0.068B 0.00
Viveve Medical (VIVE) United States $0.066B 0.00
Electromed (ELMD) United States $0.050B 24.04
OBALON THERPTCS (OBLN) United States $0.047B 0.00
Xtant Medical Holdings (XTNT) United States $0.042B 0.00
Navidea Biopharmaceuticals (NAVB) United States $0.037B 0.00
Vermillion (VRML) United States $0.036B 0.00
Neovasc (NVCN) Canada $0.035B 0.00
ConforMIS (CFMS) United States $0.033B 0.00
PAVmed (PAVM) United States $0.028B 0.00
Lianluo Smart (LLIT) China $0.028B 0.00
Titan Medical (TMDI) Canada $0.027B 0.00
Dynatronics (DYNT) United States $0.024B 0.00
DarioHealth (DRIO) Israel $0.022B 0.00
ENDRA Life Sciences (NDRA) United States $0.021B 0.00
ReWalk Robotics (RWLK) Israel $0.020B 0.00
Nanovibronix (NAOV) United States $0.016B 0.00
Presbia (LENS) Ireland $0.016B 0.00
American Shared Hospital Services (AMS) United States $0.015B 11.65
Bioanalytical Systems (BASI) United States $0.014B 0.00
Microbot Medical (MBOT) United States $0.010B 0.00
Micron Solutions (MICR) United States $0.010B 0.00
Allied Healthcare Products (AHPI) United States $0.008B 0.00
Sunshine Heart Inc (CHFS) United States $0.007B 0.00
Cesca Therapeutics (KOOL) United States $0.007B 0.00
Atossa Genetics (ATOS) United States $0.006B 0.00
InspireMD (NSPR) Israel $0.005B 0.00
Avinger (AVGR) United States $0.004B 0.00
Check-Cap (CHEK) Israel $0.000B 0.00
EnteroMedics (RSLS) United States $0.000B 0.00
Amedica (SINT) United States $0.000B 0.00